Edgewise Therapeutics, Inc. (EWTX) Analyst Estimates Quarterly - Discounting Cash Flows

Edgewise Therapeutics, Inc. (EWTX) Analyst Estimates Quarterly - Discounting Cash Flows

Edgewise Therapeutics, Inc.

EWTX (NASDAQ)

(%)

Financials
Edgewise Therapeutics, Inc. Analyst Estimates Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-30	2026 09-30	2026 06-30	2026 03-30	2025 12-30	2025 09-30
Number of Analysts	1234				0	0
Estimated Revenue
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EBITDA
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EBIT
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated Net Income
Low	1234				-51.35	-46.11
Average	1234				-46	-41.92
High	1234				-40.65	-37.73
Estimated SGA Expenses
Low	1234				0	0
Average	1234				0	0
High	1234				0	0
Estimated EPS
Low	1234				-0.487	-0.437
Average	1234				-0.436	-0.397
High	1234				-0.385	-0.358